Suppr超能文献

心脏移植术后晚期发生的房室传导阻滞:3例病例报告及文献复习

Atrioventricular block occurring late after heart transplantation: presentation of three cases and literature review.

作者信息

Cataldo R, Olsen S, Freedman R A

机构信息

Division of Cardiology, University of Utah Health Sciences Center, Salt Lake City, USA.

出版信息

Pacing Clin Electrophysiol. 1996 Mar;19(3):325-30. doi: 10.1111/j.1540-8159.1996.tb03334.x.

Abstract

Sinus node dysfunction is a well-known occurrence following orthotopic heart transplantation, but atrioventricular block is rarely described. We compare the incidence and clinical presentation of atrioventricular block and sinus node dysfunction among the first 200 consecutive patients receiving heart transplantation at the University of Utah. Two of 200 patients (1%) required pacemaker implantation for symptomatic atrioventricular block compared to 13 of 200 (6.5%) who required pacemaker for symptomatic sinus node dysfunction. Of the patients with atrioventricular block, one had intermittent Mobitz II second-degree atrioventricular block and one had high grade atrioventricular block without ventricular escape. The most striking difference between the patients with atrioventricular block and those with sinus node dysfunction was the interval between transplantation and pacemaker implantation; time to pacemaker implantation in the atrioventricular block patients was 955 and 810 days compared to a median time of 26 days for sinus node dysfunction patients (P = 0.037). The patients requiring permanent pacemaker implantation were similar to those not requiring pacemaker implantation with respect to age, sex, ischemic time, and donor age. None of the patients requiring permanent pacemaker implantation was on amiodarone therapy within 2 months of transplant.

摘要

窦房结功能障碍是原位心脏移植后常见的情况,但房室传导阻滞的描述较少。我们比较了犹他大学首批连续200例接受心脏移植患者中房室传导阻滞和窦房结功能障碍的发生率及临床表现。200例患者中有2例(1%)因有症状的房室传导阻滞需要植入起搏器,而200例中有13例(6.5%)因有症状的窦房结功能障碍需要植入起搏器。在有房室传导阻滞的患者中,1例有间歇性莫氏Ⅱ型二度房室传导阻滞,1例有高度房室传导阻滞且无室性逸搏。房室传导阻滞患者与窦房结功能障碍患者最显著的差异在于移植与起搏器植入之间的间隔时间;房室传导阻滞患者植入起搏器的时间为955天和810天,而窦房结功能障碍患者的中位时间为26天(P = 0.037)。在年龄、性别、缺血时间和供体年龄方面,需要植入永久起搏器的患者与不需要植入起搏器的患者相似。在移植后2个月内,需要植入永久起搏器的患者均未接受胺碘酮治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验